GeoVax Labs (GOVX) EBT (2016 - 2025)
Historic EBT for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$6.3 million.
- GeoVax Labs' EBT fell 865.7% to -$6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.3 million, marking a year-over-year decrease of 405.78%. This contributed to the annual value of -$25.0 million for FY2024, which is 375.27% up from last year.
- Latest data reveals that GeoVax Labs reported EBT of -$6.3 million as of Q3 2025, which was down 865.7% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, GeoVax Labs' EBT ranged from a high of -$1.5 million in Q2 2021 and a low of -$13.7 million during Q4 2021
- In the last 5 years, GeoVax Labs' EBT had a median value of -$5.4 million in 2025 and averaged -$5.3 million.
- Its EBT has fluctuated over the past 5 years, first tumbled by 92826.61% in 2021, then surged by 6082.51% in 2022.
- Quarter analysis of 5 years shows GeoVax Labs' EBT stood at -$13.7 million in 2021, then soared by 60.83% to -$5.4 million in 2022, then crashed by 41.02% to -$7.6 million in 2023, then dropped by 8.83% to -$8.3 million in 2024, then grew by 23.52% to -$6.3 million in 2025.
- Its EBT was -$6.3 million in Q3 2025, compared to -$5.4 million in Q2 2025 and -$5.4 million in Q1 2025.